Anticancer drug screening test with LDH in nude mouse bearing bone and soft part sarcoma
- 1 September 1985
- Vol. 56 (5) , 1112-1116
- https://doi.org/10.1002/1097-0142(19850901)56:5<1112::aid-cncr2820560526>3.0.co;2-a
Abstract
With the use of human LDH as a marker, growth and remission of four human osteosarcomas (KOS-1, KOS-2, KOS-3, OST) and a malignant fibrous histiocytoma (KMF) transplanted into nude mice were monitored during chemotherapies (Adriamycin [doxorubicin], cisplatin, mitomycin C, cyclophosphamide and vincristine). Four osteosarcomas were effectively treated with Adriamycin and cisplatin, and KMF was treated with Adriamycin, cisplatin, and mitomycin C. Changes in human LDH levels paralleled changes in tumor size and these could be used to predict the death of the animals due to tumor (P < 0.01). Furthermore, the enzyme increased transiently after administration of the effective drugs.This publication has 5 references indexed in Scilit:
- Correlation between response to chemotherapy of human tumors in patients and in nude miceCancer, 1983
- Lactic dehydrogenase in the monitoring and prognosis of testicular cancerCancer, 1981
- Relationship of chemotherapy on human cancer xenografts in nude mice to clinical response in donor patientJournal of Surgical Oncology, 1980
- HUMAN LACTIC-DEHYDROGENASE AS A MARKER FOR HUMAN TUMOR-CELLS GROWN IN ATHYMIC MICE1977
- Separation and quantitation of lactic dehydrogenase isoenzymes by disc electrophoresisAnalytical Biochemistry, 1967